Haemonetics OverviewHaemonetics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for HAE.
Quarterly EBIT
-$23.03M
↓ 132.28% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$152.81M
↓ 32.52% YoY
Trailing 12 months ending Mar 31, 2026
Haemonetics OverviewEBIT (Earnings Before Interest and Taxes) analysis for HAE.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026